PATENT CLAIM ANALYSIS

Application Number: 15883006
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-12
Patent Classification: ["424", "178100"]

Abstract:
The present invention relates to Fc variants with optimized Fc ligand binding properties, methods for their generation, Fc polypeptides comprising Fc variants with optimized Fc ligand binding properties, and methods for using same.

Claim (Index 16):
An antibody having specificity for HIV gp120, said antibody comprising an Fc variant of a human IgG1 Fc polypeptide, wherein said Fc variant comprises amino acid modifications S239D, A330L, and I332E in the Fc region of said human IgG1 Fc polypeptide, wherein numbering is according to the EU index.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 86.0
- Lexical Diversity: 1.6087
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['11174287', '14286825', '14578305', '14507783', '14326373']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7904647509441299
- 35 USC 102 Novelty (BERT): 0.5592341893340728
- Combined Prediction Score: 0.7673416947831242
- Mean Citation Score: 456.33584
- Max Citation Score: 493.28262
- Similarity Product: 324.66146236131186

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test